Verrica Pharmaceuticals buy Needham & Company LLC
Start price
15.08.24
/
50%
€2.62
Target price
15.08.25
€10.95
Performance (%)
-77.18%
End price
16.08.25
-
Summary
This prediction is currently being closed. Massive losses of -77.18% have been the result for the BUY prediction by Needham___Company_LL. Needham___Company_LL has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Verrica Pharmaceuticals | - | - | - |
| iShares Core DAX® | 3,59 % | 3,93 % | 15,38 % |
| iShares Nasdaq 100 | 5,81 % | 5,52 % | 41,46 % |
| iShares Nikkei 225® | 4,08 % | 8,46 % | 48,95 % |
| iShares S&P 500 | 4,14 % | 4,04 % | 31,59 % |
Comments by Needham___Company_LL for this prediction
In the thread Discuss Verrica Pharmaceuticals
Verrica Pharmaceuticals Inc. (NASDAQ: VRCA) had its price target lowered by analysts at Needham & Company LLC from $16.00 to $12.00. They now have a "buy" rating on the stock.
Ratings data for VRCA provided by MarketBeat
In the thread Trading Verrica Pharmaceuticals
Die von Needham___Company_LL gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Needham___Company_LL for Verrica Pharmaceuticals
Verrica Pharmaceuticals
Start price
Target price
Perf. (%)
€9.90
14.05.24
14.05.24
€14.81
14.05.25
14.05.25
-95.10%
15.05.25
15.05.25
Verrica Pharmaceuticals
Start price
Target price
Perf. (%)
€2.74
10.11.23
10.11.23
€7.49
10.11.24
10.11.24
-71.24%
11.11.24
11.11.24
Verrica Pharmaceuticals
Start price
Target price
Perf. (%)
€3.90
23.08.23
23.08.23
€9.25
23.08.24
23.08.24
-38.46%
24.08.24
24.08.24